5-Amino-1MQ vs KGLOW
5-Amino-1MQ and KGLOW are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: 5-Amino-1MQ is small-molecule nnmt inhibitor (methylquinolinium salt) — not a peptide, while KGLOW is four-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg / kpv 10 mg (80 mg total) — different molecular classes with different handling consequences; their leading degradation routes differ (microbial growth in non-preserved diluent for 5-Amino-1MQ, copper dissociation from the ghk-cu component at acidic ph or on chelator contact for KGLOW), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
5-Amino-1MQ — origin
5-Amino-1MQ is a small quinolinium molecule characterised as a first-in-class inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme studied at the intersection of adipocyte metabolism and the cellular NAD+/methylation pool. It is not an amino-acid chain, which is why it sits apart from every peptide in this catalogue.
KGLOW — origin
KGLOW is GLOW with a fourth component added: KPV, a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. The other three amounts are unchanged — GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg — with KPV at 10 mg bringing the vial to 80 mg. KPV is studied primarily for anti-inflammatory activity in preclinical models, notably retaining that property of the parent hormone without its pigmentation-related effects.
5-Amino-1MQ research themes
The defining mechanism — preclinical work has examined how blocking NNMT shifts methylation flux and NAD+ salvage in metabolic tissue models.
Studied in fat-cell models for effects on cellular energy handling and lipid metabolism.
Because NNMT consumes a methyl group tied to the NAD+ precursor pool, it is studied alongside the wider NAD+ research field.
KGLOW research themes
The majority component, with the deepest dermal research literature.
The addition that distinguishes KGLOW — studied for anti-inflammatory activity derived from alpha-MSH without pigmentation effects.
Two complementary tissue-repair mechanisms, unchanged from GLOW.
Adds an inflammation arm to the three repair-focused mechanisms in GLOW.
5-Amino-1MQ handling
- Let the sealed vial reach room temperature before opening so moisture does not condense onto the powder.
- For cell-based assays, prepare a concentrated DMSO stock and dilute into aqueous buffer rather than dissolving directly at high concentration in medium.
- Label aliquots with reconstitution date and diluent.
KGLOW handling
- Never reconstitute in acidic diluent — copper dissociation from the GHK-Cu component is the primary risk.
- Keep EDTA and other chelators out of any buffer used with KGLOW.
- Treat colour as data: clear even blue is correct; pale or green is not.
- Protect from light and minimise headspace exposure for the TB-500 component.
- Scale diluent to the 80 mg fill — habitually adding 2 mL as though to a 10 mg vial gives a solution eight times more concentrated than intended.
Both third-party tested
Every Popular Peptides batch of 5-Amino-1MQ and KGLOW is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
5-Amino-1MQ reference
Related comparisons
5-Amino-1MQ and KGLOW are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.